Desq Long
Sign in

Company

BridgeBio Pharma, Inc.

BBIO · CIK 0001743881

SEC FORM 4
$601,867.61

BridgeBio Pharma, Inc. (BBIO)

Sale of 8,721 shares at $69.0136 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001470831-26-000897 · filed 2026-09-21 · View filing →

SEC FORM 4
$88,979.52

BridgeBio Pharma, Inc. (BBIO)

Sale of 1,279 shares at $69.5696 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001470831-26-000897 · filed 2026-09-21 · View filing →

SEC FORM 4
$679,256.28

BridgeBio Pharma, Inc. (BBIO)

Sale of 8,100 shares at $83.8588 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$152,436.06

BridgeBio Pharma, Inc. (BBIO)

Sale of 1,800 shares at $84.6867 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$8,565.00

BridgeBio Pharma, Inc. (BBIO)

Sale of 100 shares at $85.65 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$154,183.86

BridgeBio Pharma, Inc. (BBIO)

Sale of 1,900 shares at $81.1494 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,420,513.50

BridgeBio Pharma, Inc. (BBIO)

Sale of 17,279 shares at $82.2104 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,211,852.10

BridgeBio Pharma, Inc. (BBIO)

Sale of 14,602 shares at $82.9922 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$100,444.07

BridgeBio Pharma, Inc. (BBIO)

Sale of 1,199 shares at $83.7732 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →

SEC FORM 4
$376,460.04

BridgeBio Pharma, Inc. (BBIO)

Disposition (code F) of 4,714 shares at $79.86 per share.

Reporting Person Apuli Maricel · Officer Title Chief Accounting Officer · Transaction Code F

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000835 · filed 2026-08-18 · View filing →

SEC FORM 4
—

BridgeBio Pharma, Inc. (BBIO)

Acquisition (code M) of 33,544 shares; price not stated (see filing).

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000836 · filed 2026-08-18 · View filing →

SEC FORM 4
—

BridgeBio Pharma, Inc. (BBIO)

Acquisition (code M) of 19,599 shares; price not stated (see filing).

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000836 · filed 2026-08-18 · View filing →

SEC FORM 4
—

BridgeBio Pharma, Inc. (BBIO)

Acquisition (code M) of 11,554 shares; price not stated (see filing).

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000836 · filed 2026-08-18 · View filing →

SEC FORM 4
—

BridgeBio Pharma, Inc. (BBIO)

Acquisition (code M) of 6,520 shares; price not stated (see filing).

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000836 · filed 2026-08-18 · View filing →

SEC FORM 4
$2,893,886.82

BridgeBio Pharma, Inc. (BBIO)

Disposition (code F) of 36,237 shares at $79.86 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code F

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000836 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,819,290.66

BridgeBio Pharma, Inc. (BBIO)

Disposition (code F) of 22,781 shares at $79.86 per share.

Reporting Person Trimarchi Thomas · Officer Title President and CFO · Transaction Code F

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000837 · filed 2026-08-18 · View filing →

STOCK ACT PTR
$1,001 - $15,000

BRIDGEBIO PHARMA INC (BBIO)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded May 11, 2026 · Disclosed Jun 8, 2026FILED +28 DAYS

Source: House Clerk PTR · 20034713 · filed 2026-06-08 · View filing →

STOCK ACT PTR
$1,001 - $15,000

BRIDGEBIO PHARMA INC (BBIO)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded Apr 29, 2026 · Disclosed May 8, 2026FILED +9 DAYS

Source: House Clerk PTR · 20034500 · filed 2026-05-08 · View filing →

STOCK ACT PTR
$1,001 - $15,000

BRIDGEBIO PHARMA INC (BBIO)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded Mar 19, 2026 · Disclosed Apr 7, 2026FILED +19 DAYS

Source: House Clerk PTR · 20034285 · filed 2026-04-07 · View filing →

STOCK ACT PTR
$1,001 - $15,000

BRIDGEBIO PHARMA INC (BBIO)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded Mar 18, 2026 · Disclosed Apr 7, 2026FILED +20 DAYS

Source: House Clerk PTR · 20034285 · filed 2026-04-07 · View filing →

STOCK ACT PTR
$1,001 - $15,000

BRIDGEBIO PHARMA INC (BBIO)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded Mar 3, 2026 · Disclosed Apr 7, 2026FILED +35 DAYS

Source: House Clerk PTR · 20034285 · filed 2026-04-07 · View filing →